UNASSIGNED: Participants aged 60 and above, admitted to the Department of Cardiology - Interventional and Cardiovascular Emergency of Thong Nhat Hospital in Ho Chi Minh City from November 2021 to June 2022, were recruited for the prospective, single-center study. The prognostic outcomes included all-cause death and the initial occurrence of emergency re-hospitalization within 6 months\' post-discharge. The Kaplan-Meier analysis compared the overall survival rates between different SARC-F score groups.
UNASSIGNED: The study enrolled 285 patients with a median age of 74 (67, 81). During a 6-month follow-up period, there were 14 cases of mortality. A SARC-F score of 4 or higher was significantly associated with an increased risk of all-cause mortality, with HR of 2.02 (95% CI: 1.39-2.92, p < 0.001), and higher incidence of re-hospitalization events with RR of 1.66 (95% CI: 1.06 to 2.59, p = 0.026). Kaplan-Meier survival analysis indicated a notably higher mortality rate in the patients with high SARC-F scores (p < 0.001).
UNASSIGNED: In elderly patients with cardiovascular disease, the SARC-F questionnaire could serve as a simple and cost-effective method for detecting mortality and the risk of re-hospitalization.
■60岁及以上的参与者,从2021年11月至2022年6月被胡志明市ThongNhat医院心脏病学-介入和心血管急诊部门录取,单中心研究。预后结果包括全因死亡和出院后6个月内急诊再次住院的初始发生。Kaplan-Meier分析比较了不同SARC-F评分组之间的总生存率。
■该研究招募了285名患者,中位年龄为74岁(67,81)。在6个月的随访期间,有14例死亡。SARC-F评分为4或更高与全因死亡风险增加显著相关,HR为2.02(95%CI:1.39-2.92,p<0.001),再住院事件发生率较高,RR为1.66(95%CI:1.06~2.59,p=0.026)。Kaplan-Meier生存分析显示SARC-F评分高的患者死亡率明显较高(p<0.001)。
■老年心血管疾病患者,SARC-F问卷可作为检测死亡率和再住院风险的简单且经济有效的方法.